Post by icemandios on Jan 12, 2022 13:35:55 GMT
Antares Pharma Appoints Claude E. Richardson as Senior Vice President of Human Resources
EWING, N.J., Jan. 12, 2022 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (the “Company”), a specialty pharmaceutical company, announced today the appointment of Claude E. Richardson as Senior Vice President of Human Resources. Mr. Richardson will be responsible for Antares’ corporate Human Resources (“HR”) strategy and development.
Claude E. Richardson has more than 25 years of Human Resources leadership experience across multiple industries including pharmaceutical, industrials, financial services and consumer products. His broad-based background in Human Resources includes talent management and acquisition, compensation and benefits, development and training, performance management, organizational assessment, change management and HR strategy.
Robert F. Apple, President and Chief Executive Officer of Antares Pharma, commented, “We are excited to welcome Claude to the executive leadership team at this juncture of our growth. Claude has an extensive Human Resources background that we expect will prove valuable in this new role as we continue to grow and expand. Employee engagement and a high-performance culture are key focuses for Antares, and we believe Claude will have a positive impact in these areas as well as emphasizing the acceleration of diversity, equity and inclusion efforts across the Company’s initiatives. We look forward to leveraging his proven ability to develop and manage an HR strategy that will drive performance and support our future growth.”
Prior to joining Antares, Mr. Richardson was Senior Vice President, Chief Human Resources Officer at Delta Dental of NJ/CT, a regional dental insurer with approximately 300 employees. Previously, he was Vice President, Global Human Resources at Ametek, Inc., an industrials company with approximately 18,000 employees worldwide. Prior to that, Mr. Richardson has held other senior Human Resources roles at an impressive roster of organizations including Lockheed Martin, Lubrizol Corporation, Johnson & Johnson, Citigroup, The Gillette Corporation and Texas Instruments. Mr. Richardson was also a decorated Officer in the United States Marine Corps. He earned his Bachelor of Science in General Engineering from the U.S. Naval Academy and Executive Masters in Human Resources Leadership from Rutgers University, School of Management and Labor Relations.
“I appreciate the opportunity to join Antares to lead their Human Resources strategy and development. I believe my comprehensive HR background will support the Company’s expansion and growth trajectory. I look forward to working with everyone at Antares to build and strengthen a collaborative environment for continued success,” added Mr. Richardson.
About Antares Pharma
Antares Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development and commercialization of self-administered injectable pharmaceutical products using advanced drug delivery auto injector technology. The Company has a portfolio of proprietary and partnered commercial products with several product candidates in various stages of development, as well as significant strategic alliances with industry leading pharmaceutical companies including Teva Pharmaceutical Industries, Ltd. (Teva), AMAG Pharmaceuticals (AMAG), Pfizer Inc. (Pfizer) and Idorsia Pharmaceuticals Ltd. (Idorsia). Antares Pharma’s FDA-approved products include XYOSTED ® (testosterone enanthate) injection and Sumatriptan Injection USP, which is distributed by Teva. The Company also markets NOCDURNA ® (desmopressin acetate) in the U.S. and expects to commercially launch TLANDO ® (testosterone undecanoate) in the U.S. pending final FDA approval.
EWING, N.J., Jan. 12, 2022 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (the “Company”), a specialty pharmaceutical company, announced today the appointment of Claude E. Richardson as Senior Vice President of Human Resources. Mr. Richardson will be responsible for Antares’ corporate Human Resources (“HR”) strategy and development.
Claude E. Richardson has more than 25 years of Human Resources leadership experience across multiple industries including pharmaceutical, industrials, financial services and consumer products. His broad-based background in Human Resources includes talent management and acquisition, compensation and benefits, development and training, performance management, organizational assessment, change management and HR strategy.
Robert F. Apple, President and Chief Executive Officer of Antares Pharma, commented, “We are excited to welcome Claude to the executive leadership team at this juncture of our growth. Claude has an extensive Human Resources background that we expect will prove valuable in this new role as we continue to grow and expand. Employee engagement and a high-performance culture are key focuses for Antares, and we believe Claude will have a positive impact in these areas as well as emphasizing the acceleration of diversity, equity and inclusion efforts across the Company’s initiatives. We look forward to leveraging his proven ability to develop and manage an HR strategy that will drive performance and support our future growth.”
Prior to joining Antares, Mr. Richardson was Senior Vice President, Chief Human Resources Officer at Delta Dental of NJ/CT, a regional dental insurer with approximately 300 employees. Previously, he was Vice President, Global Human Resources at Ametek, Inc., an industrials company with approximately 18,000 employees worldwide. Prior to that, Mr. Richardson has held other senior Human Resources roles at an impressive roster of organizations including Lockheed Martin, Lubrizol Corporation, Johnson & Johnson, Citigroup, The Gillette Corporation and Texas Instruments. Mr. Richardson was also a decorated Officer in the United States Marine Corps. He earned his Bachelor of Science in General Engineering from the U.S. Naval Academy and Executive Masters in Human Resources Leadership from Rutgers University, School of Management and Labor Relations.
“I appreciate the opportunity to join Antares to lead their Human Resources strategy and development. I believe my comprehensive HR background will support the Company’s expansion and growth trajectory. I look forward to working with everyone at Antares to build and strengthen a collaborative environment for continued success,” added Mr. Richardson.
About Antares Pharma
Antares Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development and commercialization of self-administered injectable pharmaceutical products using advanced drug delivery auto injector technology. The Company has a portfolio of proprietary and partnered commercial products with several product candidates in various stages of development, as well as significant strategic alliances with industry leading pharmaceutical companies including Teva Pharmaceutical Industries, Ltd. (Teva), AMAG Pharmaceuticals (AMAG), Pfizer Inc. (Pfizer) and Idorsia Pharmaceuticals Ltd. (Idorsia). Antares Pharma’s FDA-approved products include XYOSTED ® (testosterone enanthate) injection and Sumatriptan Injection USP, which is distributed by Teva. The Company also markets NOCDURNA ® (desmopressin acetate) in the U.S. and expects to commercially launch TLANDO ® (testosterone undecanoate) in the U.S. pending final FDA approval.